Extracellular Volume Fraction Calculated Using Contrast-Enhanced Computed Tomography as a Biomarker of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: A Preliminary Histopathological Analysis

Figure 1

Flowchart of study enrollment. CRLM, colorectal liver metastasis; CT, computed tomography; IRI, irinotecan; and OX, oxaliplatin.